DE3344001A1 - HYDROPHILE POLYURETHANE ACRYLATE COMPOSITION AND THEIR USE - Google Patents
HYDROPHILE POLYURETHANE ACRYLATE COMPOSITION AND THEIR USEInfo
- Publication number
- DE3344001A1 DE3344001A1 DE19833344001 DE3344001A DE3344001A1 DE 3344001 A1 DE3344001 A1 DE 3344001A1 DE 19833344001 DE19833344001 DE 19833344001 DE 3344001 A DE3344001 A DE 3344001A DE 3344001 A1 DE3344001 A1 DE 3344001A1
- Authority
- DE
- Germany
- Prior art keywords
- acrylate
- composition according
- parts
- composition
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims description 53
- 239000004814 polyurethane Substances 0.000 title claims description 32
- 229920002635 polyurethane Polymers 0.000 title claims description 32
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 title claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical group COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 10
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 9
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical group CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 125000005442 diisocyanate group Chemical group 0.000 claims description 7
- 229920005862 polyol Polymers 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 4
- 239000003433 contraceptive agent Substances 0.000 claims description 4
- 230000002254 contraceptive effect Effects 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 4
- 239000000017 hydrogel Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 3
- 239000007943 implant Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 241001631457 Cannula Species 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 238000012377 drug delivery Methods 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 229940126701 oral medication Drugs 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000000465 moulding Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- -1 nitrile carbonates Chemical class 0.000 description 15
- 239000003054 catalyst Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 150000002596 lactones Chemical class 0.000 description 8
- 239000012948 isocyanate Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000002513 isocyanates Chemical class 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 150000002009 diols Chemical class 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920005749 polyurethane resin Polymers 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- VZXPHDGHQXLXJC-UHFFFAOYSA-N 1,6-diisocyanato-5,6-dimethylheptane Chemical compound O=C=NC(C)(C)C(C)CCCCN=C=O VZXPHDGHQXLXJC-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 239000005058 Isophorone diisocyanate Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- 239000012975 dibutyltin dilaurate Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000011953 free-radical catalyst Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 229920001515 polyalkylene glycol Polymers 0.000 description 2
- 239000005056 polyisocyanate Substances 0.000 description 2
- 229920001228 polyisocyanate Polymers 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000011342 resin composition Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- OGLCQHRZUSEXNB-UAPNVWQMSA-N (2r,3r,3ar,6ar)-2,3,6-trihydroxy-3,3a,6,6a-tetrahydro-2h-furo[3,2-b]furan-5-one Chemical compound OC1C(=O)O[C@@H]2[C@@H](O)[C@H](O)O[C@@H]21 OGLCQHRZUSEXNB-UAPNVWQMSA-N 0.000 description 1
- RTTZISZSHSCFRH-UHFFFAOYSA-N 1,3-bis(isocyanatomethyl)benzene Chemical compound O=C=NCC1=CC=CC(CN=C=O)=C1 RTTZISZSHSCFRH-UHFFFAOYSA-N 0.000 description 1
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- QZWKEPYTBWZJJA-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine-4,4'-diisocyanate Chemical compound C1=C(N=C=O)C(OC)=CC(C=2C=C(OC)C(N=C=O)=CC=2)=C1 QZWKEPYTBWZJJA-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- CCFQKJBRMQOAFR-UHFFFAOYSA-N N=C=O.N=C=O.CCC1=CC=CC=C1CC Chemical compound N=C=O.N=C=O.CCC1=CC=CC=C1CC CCFQKJBRMQOAFR-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- YGXPXNPJGDEFTN-UHFFFAOYSA-N carbonic acid;hexanedinitrile Chemical compound OC(O)=O.N#CCCCCC#N YGXPXNPJGDEFTN-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 229950002441 glucurolactone Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 239000003832 thermite Substances 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M50/00—Constructional details or processes of manufacture of the non-active parts of electrochemical cells other than fuel cells, e.g. hybrid cells
- H01M50/40—Separators; Membranes; Diaphragms; Spacing elements inside cells
- H01M50/409—Separators, membranes or diaphragms characterised by the material
- H01M50/411—Organic material
- H01M50/414—Synthetic resins, e.g. thermoplastics or thermosetting resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/54—Polyureas; Polyurethanes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/76—Macromolecular material not specifically provided for in a single one of groups B01D71/08 - B01D71/74
- B01D71/78—Graft polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
- C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
- C08F299/06—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polyurethanes
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M50/00—Constructional details or processes of manufacture of the non-active parts of electrochemical cells other than fuel cells, e.g. hybrid cells
- H01M50/40—Separators; Membranes; Diaphragms; Spacing elements inside cells
- H01M50/489—Separators, membranes, diaphragms or spacing elements inside the cells, characterised by their physical properties, e.g. swelling degree, hydrophilicity or shut down properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L2300/222—Steroids, e.g. corticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/10—Energy storage using batteries
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Electrochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Polyurethanes Or Polyureas (AREA)
Description
33443344
Beschreibungdescription
Die Erfindung bezieht sich auf hydrophile Polyurethan-Acrylat-Zusammensetzungen. Sie ist insbesondere auf Zusammensetzungen gerichtet, die man durch Umsetzung eines oder mehrerer Acrylate in Gegenwart eines oder mehrerer hydrophiler Polyurethane erhält, zu denen man durch Umsetzung eines Polyalkylenglykols mit einem Diisocyanat gelangenThe invention relates to hydrophilic polyurethane-acrylate compositions. It is particularly directed to compositions that can be obtained by reacting one or several acrylates obtained in the presence of one or more hydrophilic polyurethanes, to which one can react of a polyalkylene glycol with a diisocyanate
kann.can.
In DE-OS 31 45 003 werden bereits Polyurethan-Diacrylat-Zusammensetzungen beschrieben, die in einem Alkohol, wie Ethanol oder Methanol, praktisch unlöslich sind. Genauso wie diese bekannten Zusammensetzungen bilden die erfindungsgemäßen hydrophilen Polyurethan-Acrylat-Zusammensetzungen nach Eintauchen in Wasser ein Hydrogel und sind durchlässig für Gase, Ionen und nichtionische Materialien unterschiedlicher Molekulargewichte. Im Gegensatz zu den bekannten hydrophilen Polyurethan-Diacrylat-Zusammensetzungen lösen sich die vorliegenden Zusammensetzungen jedoch in Alkohol.In DE-OS 31 45 003 polyurethane diacrylate compositions are already described, which are practically insoluble in an alcohol such as ethanol or methanol. Just like that like these known compositions, form the hydrophilic polyurethane-acrylate compositions of the invention after immersion in water a hydrogel and are permeable to gases, ions and non-ionic materials different molecular weights. In contrast to the known hydrophilic polyurethane diacrylate compositions however, the present compositions dissolve in alcohol.
Die erfindungsgemäßen hydrophilen Polyurethan-Acrylat-Zusammensetzungen lassen sich herstellen, indem man ein Acrylat in Gegenwart eines oder mehrerer hydrophiler Polyurethane umsetzt. Die Umsetzung des Acrylats kann durch Anwesenheit eines frei radikalischen Katalysators eingeleitetThe hydrophilic polyurethane-acrylate compositions according to the invention can be prepared by adding an acrylate in the presence of one or more hydrophilic polyurethanes implements. The reaction of the acrylate can be initiated by the presence of a free radical catalyst
werden.
30will.
30th
Die als eine Komponente der erfindungsgemäßen hydrophilen
Polyurethan-Acrylat-Zusammensetzung benötigten hydrophilen Polyurethane können hergestellt werden durch Umsetzung von
(A) ein oder mehr Diolen mit einem zahlenmittleren Moleku-1argewicht
im Bereich von etwa 106 bis 20000 aus der Gruppe von
(a) Diethylenglykol,The hydrophilic polyurethanes required as a component of the hydrophilic polyurethane-acrylate composition according to the invention can be prepared by reacting (A) one or more diols having a number average molecular weight in the range from about 10 6 to 20,000 from the group of
(a) diethylene glycol,
isseat
(b) langkettigen Polyoxyalkylendiolen und/oder(b) long-chain polyoxyalkylene diols and / or
(c) Dialkanolaminen,(c) dialkanolamines,
mitwith
(B) einem Urethanvorläufer aus der Gruppe der Organopoly- ° isocyanate und/oder Nitrilcarbonate in Gegenwart eines Organozinn-Katalysators.(B) a urethane precursor from the group of organopoly isocyanates and / or nitrile carbonates in the presence of an organotin catalyst.
Gewünschtenfalls kann diese Umsetzung auch unter Zusatz eines polyfunktionellen Lactons der allgemeinen Formel 10If desired, this reaction can also be carried out with the addition of a polyfunctional lactone of the general formula 10
Rn, - CH - R2 - C = OR n , - CH - R 2 - C = O
worin R, einen einwertigen Rest aus der Gruppe -H, -CH9NH9, -SO9CH , -CHOHCOOH und/oder -(CHOH) CH9OH bedeutet, wobei η für eine Zahl von 0 bis 5 steht, und R9 einen zweiwertigen Rest der allgemeinen Formelwherein R, is a monovalent radical from the group -H, -CH 9 NH 9 , -SO 9 CH, -CHOHCOOH and / or - (CHOH) CH 9 OH, where η is a number from 0 to 5, and R 9 is a divalent radical of the general formula
-(-CH)H) - darstellt, worin m für eine Zahl von 2 bis 10 m- (- CH) H) - where m is a number from 2 to 10 m
steht, oder eines von solchen Lactonen abgeleiteten Ethers in Mengen von 0,1 bis 30 Gew.-% auf das gesamte Reaktionsgemisch bezogen durchgeführt werden. or an ether derived from such lactones can be carried out in amounts of 0.1 to 30% by weight based on the total reaction mixture.
Polyurethanharze, die solche polyfunktionelle Lactone enthalten, werden beispielsweise in US-PS 4 156 066 und US-PS 4 156 067 beschrieben.Polyurethane resins containing such polyfunctional lactones, are described, for example, in U.S. Patent 4,156,066 and U.S. Patent 4,156,067.
Die hydrophile Polyurethan-Komponente, die zusammen mit dem Acrylat zum Zeitpunkt seiner Umsetzung vorhanden ist, enthält Diethylenglykol und ein langkettiges Diol. Die langkettigen Diole sollen ein Molekulargewicht von wenigstens etwa 106, und vorzugsweise von 1450 bis 7500, haben. Geeignete Diole bestehen vorwiegend aus Oxyethylengruppen oder Oxypropylengruppen, obwohl auch andere Oxyalkylengruppen in geringerer Menge vorhanden sein können.The hydrophilic polyurethane component, which is present together with the acrylate at the time of its conversion, contains diethylene glycol and a long-chain diol. The long chain diols should have a molecular weight of at least about 106, and preferably from 1,450 to 7,500. Suitable diols mainly consist of oxyethylene groups or oxypropylene groups, although other oxyalkylene groups as well may be present in smaller quantities.
Das zur Herstellung der ersten Komponente der erfindungs-That for the production of the first component of the invention
gemäßen hydrophilen Polyurethan-Acrylat-Zusammensetzung verwendete Polyisocyanat hat die allgemeine Formel R(NCO) , worin η größer als 1 ist und vorzugsweise 2 bis 4 ausmacht und der Substituent R einen aliphatischen, alicyclisehen, aliphatisch-alicyclischen, aromatischen oder aliphatisch-aromatischen Kohlenwasserstoffrest mit 4 bis 26 Kohlenstoffatomen bedeutet, der vorzugsweise 6 bis 20 Kohlenstoff atome, und insbesondere 6 bis 13 Kohlenstoffatome, enthält. Beispiele für solche Isocyanate sind Tetramethylendiisocyanat, Hexamethylendiisocyanat, Trimethylhexamethylendiisocyanat. Dimersäurediisocyanat, Isophorondiisocyanat, Diethylbenzoldiisocyanat, Decamethylen-lflO-diisocyanat, Cyclohexylen-1,2-diisocyanat oder Cyclohexylen-1,4-diisocyanat, die aromatischen Isocyanate, wie 2,4- und 2,6-To-Polyisocyanate used according to the hydrophilic polyurethane-acrylate composition has the general formula R (NCO), where η is greater than 1 and preferably 2 to 4 and the substituent R is an aliphatic, alicyclic, aliphatic-alicyclic, aromatic or aliphatic-aromatic Denotes hydrocarbon radical with 4 to 26 carbon atoms, which is preferably 6 to 20 carbon atoms, and in particular 6 to 13 carbon atoms, contains. Examples of such isocyanates are tetramethylene diisocyanate, Hexamethylene diisocyanate, trimethylhexamethylene diisocyanate. Dimer acid diisocyanate, isophorone diisocyanate, diethylbenzene diisocyanate, decamethylene lflO diisocyanate, Cyclohexylene-1,2-diisocyanate or cyclohexylene-1,4-diisocyanate, the aromatic isocyanates, such as 2,4- and 2,6-To-
1^ lylendiisocyanat, 4,4-Diphenylmethandiisocyanat, 1,5-Naphthalindiisocyanat oder Dianisidindiisocyanat, Tolidindiisocyanat, polymere Isocyanate, wie Neopentyltetraisocyanat, m-Xylylendiisocyanat, Tetrahydronaphthalin-l,5-diisocyanat oder Bis(4-isocyanatphenyl)methan. 1 ^ lylene diisocyanate, 4,4-diphenylmethane diisocyanate, 1,5-naphthalene diisocyanate or dianisidine diisocyanate, tolidine diisocyanate, polymeric isocyanates such as neopentyl tetraisocyanate, m-xylylene diisocyanate, tetrahydronaphthalene-1,5-diisocyanate or bis (4-isocyanatophenyl).
Das bevorzugte Isocyanat ist Methylendi(cyclohexylisocyanat).
Zu anderen etwas weniger bevorzugten Diisocyanaten gehören Trimethylhexamethylendiisocyanat und Isophorondiisocyanat.
25The preferred isocyanate is methylene di (cyclohexyl isocyanate). Other somewhat less preferred diisocyanates include trimethyl hexamethylene diisocyanate and isophorone diisocyanate.
25th
Andere brauchbare Verbindungen sind die Isocyanatäquivalente, welche die Urethanbrücken bilden, wie die Nitrilcarbonate, beispielsweise das Adiponitrilcarbonat der FormelOther useful compounds are the isocyanate equivalents which form the urethane bridges, such as the nitrile carbonates, for example the adiponitrile carbonate of the formula
0 00 0
Il IlIl Il
0 0 00 0 0
Zur Herstellung der erfindungsgemäß benötigten hydrophilen Polyurethanharz-Komponente kann man dem ReaktionsgeTo produce the hydrophilic ones required according to the invention Polyurethane resin component can be the reaction
misch niedermolekulare Glykole, wie Diethylenglykol oder Dipropylenglykol, oder auch aromatische Glykole zusetzen. Die bevorzugten niedermolekularen aromatischen Polyoleadd mixed low molecular weight glycols, such as diethylene glycol or dipropylene glycol, or even aromatic glycols. The preferred low molecular weight aromatic polyols
sind Bisphenol A und 4,4'-SuIfonyldiphenol. 5are bisphenol A and 4,4'-sulfonyldiphenol. 5
Die Mengenanteile, in denen das langkettige Polyglykol und das niedermolekulare Glykol, wie Diethylenglykol, in der erfindungsgemäß benötigten hydrophilen Polyurethan-Komponente vorhanden sind, sind abhängig vom hydrophoben-hydrophilen Gleichgewicht, das in der jeweiligen Verbindung vorhanden ist und für die fertige Zusammensetzung gewünscht wird. Eine Erhöhung des Molekulargewichts des langkettigen Polyoxyethylenglykols und/oder der Menge dieses Polyols verleiht dem fertigen Produkt starke hydrophile Eigenschäften. Diesem Einfluß kann durch Erhöhung des Mengenanteils an niedermolekularem Glykol, wie Diethylenglykol oder Dipropylenglykol, entgegengewirkt werden.The proportions in which the long-chain polyglycol and the low molecular weight glycol, such as diethylene glycol, are in the hydrophilic polyurethane components required according to the invention are present, depend on the hydrophobic-hydrophilic Balance that is present in the particular compound and desired for the finished composition will. An increase in the molecular weight of the long chain polyoxyethylene glycol and / or the amount of this polyol gives the finished product strong hydrophilic properties. This influence can be avoided by increasing the proportion of low molecular weight glycol, such as diethylene glycol or dipropylene glycol.
Unter Berücksichtigung dieses Sachverhalts (wonach die hydrophilen Eigenschaften von der Anzahl an Polyethylenoxidgruppen im Polymermolekül bestimmt werden) lassen sich dann ohne weiteres solche Mischungen an Reaktanten auswählen, daß die hydrophilen Polyurethane, die zum Zeitpunkt der Umsetzung des Acrylats vorhanden sein müssen, über die gewünschten Eigenschaften verfügen. Durch Auswahl des Molekulargewichts des Polyethylenglykols oder durch Verwen-. dung von zwei Polyalkylenglykolen mit unterschiedlichem Molekulargewicht läßt sich die hydrophile Polyurethankomponente gewissermaßen so maßschneidern, daß sie einem breiten Eigenschaftsbereich genügt. Unter hydrophilen Polyurethanen werden vorliegend selbstverständlich solche Polyurethane verstanden, die durch Wasserstoffbindung Hydrogele bilden und die nach Eintauchen in Wasser wenigstens 20 Gew.-% Wasser aufnehmen. Die erfindungsgemäßen hydrophilen Polyurethan-Acrylat-Zusammensetzungen bilden genauso wie die hydrophile Polyurethan-Komponente nach Eintauchen in Wasser auch Hydrogele, die wenigstens 20 Gew.-% Wasser auf-Taking this into account (according to which the hydrophilic Properties can be determined by the number of polyethylene oxide groups in the polymer molecule) then readily select such mixtures of reactants that the hydrophilic polyurethanes used at the time the implementation of the acrylate must be present, have the desired properties. By choosing the molecular weight of polyethylene glycol or by using. formation of two polyalkylene glycols with different Molecular weight, the hydrophilic polyurethane component can be tailored to a certain extent so that it has a broad molecular weight Property area is sufficient. In the present context, hydrophilic polyurethanes are of course such polyurethanes understood, which form hydrogels by hydrogen bonding and which after immersion in water at least 20 Absorb wt .-% water. The hydrophilic according to the invention Polyurethane-acrylate compositions, like the hydrophilic polyurethane component, form after immersion in Water also hydrogels that contain at least 20% by weight of water
nehmen.to take.
Die hydrophile Polyurethan-Komponente, die mit einem Acrylat unter Bildung der erfindungsgemäßen Zusammensetzungen umgesetzt wird, kann obigen Angaben zufolge auch ein polyfunktionelles Lacton enthalten. Beispiele für solche polyfunktionelle Lactone sind diejenigen, die sich von Polysacchariden und Monosacchariden ableiten, wie Mannolacton, Delta-Gluconolacton, Sorbolacton oder D-Glucuronolacton.The hydrophilic polyurethane component made with an acrylate is reacted to form the compositions according to the invention, according to the above information, a polyfunctional Contain lactone. Examples of such polyfunctional Lactones are those that are derived from polysaccharides and monosaccharides, such as mannolactone, Delta-gluconolactone, sorbolactone or D-glucuronolactone.
Die zu verwendenden Lactone enthalten in ihrem Molekül zweckmäßigerweise wenigstens drei und vorzugsweise vier oder mehr Hydroxygruppen und verfügen über wenigstens eine Hydroxygruppe mehr als man zur Bildung einer linearen Polyurethankette braucht. Diese freien (nicht umgesetzten) Hydroxygruppen verbleiben in der Polymer-Grundkette und sind für eine Vernetzung des Polymers verfügbar. Der Lactonring ist ebenfalls reaktionsfähig und kann geöffnet werden, beispielsweise durch Hydrolyse, wodurch in der Polymer-Grundkette Carboxylatgruppen oder Carboxygruppen gebildet werden.The lactones to be used advantageously contain at least three and preferably four in their molecule or more hydroxyl groups and have at least one more hydroxyl group than one to form a linear polyurethane chain needs. These free (unreacted) hydroxyl groups remain in the polymer backbone and are available for crosslinking the polymer. The lactone ring is also reactive and can be opened be, for example, by hydrolysis, creating in the polymer backbone Carboxylate groups or carboxy groups are formed.
Zur Herstellung der ersten erfindungsgemäß benötigten Komponente vermischt man die Glykole mit dem eventuell zu verwendenden Lacton und setzt das jeweilige Polyisocyanat dann mit dem erhaltenen Gemisch um. Statt dessen können jedoch auch andere Techniken angewandt werden. Die Umsetzung wird unter Verwendung hierzu üblicher Katalysatoren durchgeführt, zweckmäßigerweise von Zinnsalzen oder Organozinnestern, wie Dibutylzinndilaurat, tertiäre Amine, wie Triethyldiamin (DABCD), N,N,N1,N'-Tetramethyl-l^-butandiamin, oder sonstigen für Urethanreaktionen bekannten Katalysatoren. Die Umsetzung kann in Abwesenheit oder Anwesenheit eines Verdünnungsmittels oder Lösungsmittels durchgeführt werden.To produce the first component required according to the invention, the glycols are mixed with the lactone that may be used and the respective polyisocyanate is then reacted with the mixture obtained. However, other techniques can be used instead. The reaction is carried out using catalysts customary for this purpose, expediently tin salts or organotin esters such as dibutyltin dilaurate, tertiary amines such as triethyldiamine (DABCD), N, N, N 1 , N'-tetramethyl-1 ^ -butanediamine, or others known for urethane reactions Catalysts. The reaction can be carried out in the absence or presence of a diluent or solvent.
Die zweite Komponente der erfindungsgemäßen ZusammensetzungThe second component of the composition according to the invention
3344C313344C31
ist ein Acrylat. Hierunter sind vorliegend Monoacrylsäureester oder Monomethacrylsäureester eines Alkohols mit weniger als 13 Kohlenstoffatomen zu verstehen, die hergestellt werden können durch Umsetzung von einem Mol Acrylsäure oder Methacrylsäure mit einem Mol Alkohol. Die bevorzugten Acrylate sind Hydroxyethylmethacrylat, Methylmethacrylat und Methylacrylat, wobei jedoch auch andere Ester von Acrylsäure und Methacrylsäure verwendet werden können.is an acrylate. In the present case, these include monoacrylic acid esters or monomethacrylic acid esters of an alcohol with less to be understood as 13 carbon atoms that are produced can be made by reacting one mole of acrylic acid or methacrylic acid with one mole of alcohol. The preferred Acrylates are hydroxyethyl methacrylate, methyl methacrylate and methyl acrylate, although others are also possible Esters of acrylic acid and methacrylic acid can be used.
Zur Herstellung der erfindungsgemäßen hydrophilen Polyurethan-Acrylat-Zusammensetzung löst man 100 Gew.-Teile eines oder mehrerer Polyurethane vorzugsweise zusammen mit etwa 10 bis etwa 50 Gew.-Teilen eines oder mehrerer Acrylate in einem Lösungsmittel, wie Methanol oder 95 %-igem Ethanol, und versetzt die jeweilige Lösung dann zur Einleitung der Polymerisation des Acrylats mit einem frei radikalischen Katalysator. Die Lösung der beiden Komponenten kann zu einem Film vergossen und durch Erwärmen auf Temperaturen im Bereich von 110 bis 135°C gehärtet werden, oder man kann den vergossenen Film wahlweise auch unter dem Einfluß von Ultraviolettlicht härten. Möchte man die aus zwei Komponenten bestehende Zusammensetzung durch Initiierung mit Ultraviolettlicht unlöslich machen, dann braucht hierzu kein frei radikalischer Katalysator vorhanden zu sein. Der Zusatz eines Ultraviolettabsorbers, wie Rhodamin B, oder eines Azokatalysators, wie Äzobisisobuttersäurenitril, zum Gemisch aus den beiden Komponenten kann jedoch zweckmäßig sein.For producing the hydrophilic polyurethane-acrylate composition according to the invention dissolve 100 parts by weight of one or more polyurethanes, preferably together with about 10 to about 50 parts by weight of one or more acrylates in a solvent such as methanol or 95% ethanol, and then adds a free radical to the respective solution to initiate the polymerization of the acrylate Catalyst. The solution of the two components can be cast into a film and heated to temperatures be cured in the range from 110 to 135 ° C, or you can optionally also the cast film under the influence cure from ultraviolet light. If you want to initiate the composition consisting of two components To make ultraviolet light insoluble, a free radical catalyst does not need to be present. Of the Addition of an ultraviolet absorber, such as Rhodamine B, or an azo catalyst, such as Äzobisisobutyronitrile, to the However, a mixture of the two components can be expedient.
Möchte man aus den erfindungsgemäßen hydrophilen Polyurethan-Acrylat-Zusammensetzungen Formgegenstände oder Schläuche herstellen, dann kann man hierzu das Lösungsmittel einfach unter verringertem Druck entfernen und das zurückbleibende Gemisch bei Temperaturen von 110 bis 1350C während etwa 20 bis 60 Minuten formen, um die hydrophile Polyurethan-Acrylat-Zusammensetzung hierdurch zu härten.If you want to produce molded articles or tubes from the hydrophilic polyurethane-acrylate compositions according to the invention, then you can simply remove the solvent under reduced pressure and shape the remaining mixture at temperatures of 110 to 135 0 C for about 20 to 60 minutes to make the hydrophilic To cure the polyurethane-acrylate composition.
©ÄS© ÄS
3344GG13344GG1
Die erfindungsgemäßen hydrophilen Polyurethan-Acrylat-Zusammensetzungen absorbieren Wasser, und die Wassermenge, die absorbiert wird, läßt sich durch die Art des vorhandenen hydrophilen Polyurethans und durch die Menge und Art des in der Zusammensetzung vorhandenen Acrylats verändern.The hydrophilic polyurethane-acrylate compositions according to the invention absorb water, and the amount of water that is absorbed can be determined by the type of hydrophilic polyurethane present and by the amount and type of the acrylate present in the composition.
Die oben beschriebenen hydrophilen Polyurethanacrylatharz-Zusammensetzungen eignen sich auch als Überzugsmassen, Formverbindungen, Absorbentien, Mittel zur gesteuerten Wirkstofffreigäbe, Ionenaustauscherharze und in der Zahntechnik sowie zur Herstellung von Dialysemembranen, Kanülen, Kontaktlinsen, Packungskomponenten, Entsalzungsmembranen, Brandwundenüberzügen, empfängnisverhütenden Vorrichtungen, chirurgischen Nahtmaterialien, chirurgischen Implantaten, Blutoxygenatoren, Intrauterinvorrichtungen, Gefäßprothesen, oralen Wirkstoffabgabesystemen, Batterietrennplatten, Augenbandagen, Cornealprothesen, Antibeschlagüberzügen, chirurgischen Tüchern und Bandagen, Sauerstoff austauschermembranen, künstlichen Fingernägeln, Fingerlingen, Heftpflastern, Klebstreifen, gasdurchlässigen Membranen, Schutzüberzügen und den Reibungswiderstand erniedrigenden überzügen.The above-described hydrophilic polyurethane acrylate resin compositions are also suitable as coating compounds, molded compounds, absorbents, agents for controlled Active ingredient releases, ion exchange resins and in dental technology as well as for the production of dialysis membranes, cannulas, contact lenses, packaging components, desalination membranes, Burn covers, contraceptive devices, surgical sutures, surgical Implants, blood oxygenators, intrauterine devices, vascular prostheses, oral drug delivery systems, battery separation plates, Eye bandages, corneal prostheses, anti-fog covers, surgical cloths and bandages, oxygen exchange membranes, artificial fingernails, Finger cots, adhesive plasters, adhesive strips, gas-permeable membranes, protective coatings and frictional resistance degrading coatings.
Die Erfindung wird im folgenden anhand von Beispielen weiter erläutert.The invention is further illustrated below with the aid of examples.
Zur Herstellung eines Polyurethanpolymers verschmilzt man in einem Behälter 822,3 Teile eines Polyethylenglykols mit einem zahlenmittleren Molekulargewicht von 8000 (CARBOWAX 8000 von Union Carbide Corporation, New York, New York 10017, V.St.A.), 23,0 Teile Diethylenglykol und 5,4 Teile Wasser. Das Gemisch wird bei etwa 800C klar und dann auf 75°C abgekühlt. Nach Erreichen dieser Temperatur von 75°C werden 149,7 Teile Methylenbiscyclohexyl-4,4"-isocyanat (nämlich DESMODUR W ^" von Mobay Chemical Corporation, PennTo produce a polyurethane polymer, 822.3 parts of a polyethylene glycol with a number average molecular weight of 8000 (CARBOWAX 8000 from Union Carbide Corporation, New York, New York 10017, V.St.A.), 23.0 parts of diethylene glycol and 5.4 parts of water. The mixture is clear and then cooled at about 80 0 C and at 75 ° C. After this temperature of 75 ° C. has been reached, 149.7 parts of methylenebiscyclohexyl-4,4 "isocyanate (namely DESMODUR W ^" from Mobay Chemical Corporation, Penn
BAD ORIGINALBATH ORIGINAL
Lincoln Parkway West, Pittsburgh, Pennsylvania 15205, V.St.A.) zugesetzt. Das Gemisch wird 15 Minuten bei 75°C gerührt, auf 500C abgekühlt und dann mit 2,0 Volumenteilen von Dibutylzinndilaurat als Katalysator (nämlich des Organozinnkatalysators mit der Bezeichnung T,2 von Metal and Thermite Company of Rahway, New Jersey, V.St.A.) versetzt. Nach Zugabe des Katalysators läßt man das Reaktionsgemisch durch exotherme Erwärmung von 500C auf 750C kommen. Das geschmolzene Produkt wird dann bei einer Temperatur von 75°c in Polypropylenbleche gegossen und in einem Ofen auf 1000C erhitzt, wodurch es unter Vervollständigung der Reaktion zur Bildung eines geschäumten hydrophilen Polyurethanprodukts kommt. Nach Eintauchen in Wasser absorbieren 100 Teile dieses Produkts 470 Teile Wasser, was einer Wasser-Lincoln Parkway West, Pittsburgh, Pennsylvania 15205, V.St.A.). The mixture is stirred for 15 minutes at 75 ° C, cooled to 50 0 C and then with 2.0 parts by volume of dibutyltin dilaurate as catalyst (namely, the organotin catalyst with the label T, 2 of Metal and Thermite Company of Rahway, New Jersey, V. St.A.) moved. After the catalyst has been added, the reaction mixture is allowed to come from 50 ° C. to 75 ° C. by exothermic heating. The molten product is poured into polypropylene sheets and heated in an oven at 100 0 C, which causes under the completion of the reaction for the formation of a foamed hydrophilic polyurethane product c then at a temperature of 75 °. When immersed in water, 100 parts of this product absorbs 470 parts of water, which is a water-
!5 aufnahme von 470 % entspricht.! 5 corresponds to an uptake of 470%.
Das Polyurethanprodukt wird auf Raumtemperatur abgekühlt, aus den Blechen entnommen und in 95 %-igem Ethanol gelöst, wodurch man zu einer Losung mit einem Feststoffgehalt von 9,82 Gew.-% gelangt. 305,5 Teile dieser Polyurethanlösung in Ethanol versetzt man dann unter Rühren mit 6,0 Teilen Hydroxyethylmethacrylat und 0,427 Vol.-Teilen t-Butylperoctanoat. Sodann wird das Lösungsmittel bei Raumtemperatur unter Vakuum verdampft, wodurch man ein Produkt erhält, das 100 Teile hydrophiles Polyurethan und 20 Teile Hydroxyethylmethacrylat enthält und das man anschließend bei einer Temperatur von 1210C 20 Minuten härtet. Nach erfolgter Härtung zeigt dieses Produkt eine Wasseraufnahme von 408 bis 428 % und weist einen Dehnwert von 70 bis 75 % auf.The polyurethane product is cooled to room temperature, removed from the metal sheets and dissolved in 95% strength ethanol, resulting in a solution with a solids content of 9.82% by weight. 6.0 parts of hydroxyethyl methacrylate and 0.427 parts by volume of t-butyl peroctanoate are then added to 305.5 parts of this polyurethane solution in ethanol, while stirring. The solvent is then evaporated at room temperature under vacuum, whereby a product is obtained which contains 100 parts of hydrophilic polyurethane and 20 parts of hydroxyethyl methacrylate and which is then cured at a temperature of 121 ° C. for 20 minutes. After curing, this product shows a water absorption of 408 to 428% and an elongation value of 70 to 75%.
..
• Durch Spinnen aus einer Lösung lassen sich Kontaktlinsen herstellen. Das Gemisch aus 305,5 Teilen Polyurethanlösung in Ethanol, 6,0 Teilen Hydroxyethylmethacrylat und 0,427 Vol.-Teilen t-Butylperoctanoat gemäß obigem Beispiel 1 wird unter Vakuum zur Erhöhung seines Feststoffgehalts so• Contact lenses can be made by spinning from a solution. The mixture of 305.5 parts of polyurethane solution in ethanol, 6.0 parts of hydroxyethyl methacrylate and 0.427 parts by volume of t-butyl peroctanoate according to Example 1 above is so under vacuum to increase its solids content
lange eingedampft, bis die Lösung eine Viskosität von 12 bis 15 dPa.s (12 bis 15 Poise) (etwa 11 bis 12 % nichtflüchtige Anteile) erreicht hat. evaporated for a long time until the solution has a viscosity of 12 to 15 dPa.s (12 to 15 poise) (about 11 to 12% non-volatile content).
Eine konkave Form, die der gewünschten Gestalt der konvexen Seite einer Kontaktlinse entspricht, wird auf eine vertikale Welle montiert, die sich mit einer Maximalgeschwindigkeit von 200 Umdrehungen pro Minute drehen läßt.A concave shape that corresponds to the desired shape of the convex side of a contact lens is converted to a vertical one Mounted shaft that can be rotated at a maximum speed of 200 revolutions per minute.
Der konkave Teil der Form wird zur Hälfte mit der Lösung mit einer Viskosität von 12 bis 15 dPa.s gefüllt. Die Form wird langsam in Bewegung gesetzt und innerhalb von 5 Minuten auf Maximalgeschwindigkeit gebracht. Sodann läßt man sie noch weitere 5 Minuten bei der Maximalgeschwindigkeit drehen. Anschließend läßt man die Spinnform zur Ruhe kommen.Half of the concave part of the mold is filled with the solution with a viscosity of 12 to 15 dPa.s. the Form is slowly set in motion and brought to maximum speed within 5 minutes. Then let it turn for another 5 minutes at maximum speed. Then you leave the spinning form come to rest.
Die Form wird dann in einen unter Stickstoffatmosphäre befindlichen Ofen gegeben. Die Ofentemperatur wird langsam auf 125°C angehoben und 20 Minuten beibehalten. Nach Abkühlung wird die Form in Wasser gegeben, wodurch das Polymerisat Wasser aufnimmt und von der Form getrennt wird.The mold is then placed in a nitrogen atmosphere Given oven. The oven temperature is slowly raised to 125 ° C. and maintained for 20 minutes. After cooling down the mold is placed in water, whereby the polymer absorbs water and is separated from the mold.
Gewünschtenfalls kann man die im obigen Beispiel 1 beschriebene Polyurethan-Hydroxyethylmethacrylat-Zusammensetzung vor der Stufe der Härtung auch mit pharmazeutichen Wirkstoffen vermischen oder zu deren Einkapselung verwenden. Wirkstoffe, die sich auf diese Weise verteilen lassen, sind beispielsweise Vitamine, Hormone, Steroide, Wirkstoffprotagonisten und Wirkstoffe gegen Tuberkel.If desired, those described in Example 1 above can be used Polyurethane-hydroxyethyl methacrylate composition before the stage of curing also with pharmaceutical Mix active ingredients or use them to encapsulate them. Active ingredients that can be distributed in this way, are for example vitamins, hormones, steroids, active ingredient protagonists and active ingredients against tubercles.
Ein in dieser Weise hergestelltes und gehärtetes Polymer setzt den Wirkstoff unter dem Einfluß wäßriger Lösungen, Salzlösungen oder Körperflüssigkeiten langsam frei. Die gg in diesem Beispiel beschriebene Harzzusammensetzung kann daher in jede geeignete Form gebracht werden, nämlich beispielsweise zu Tabletten für eine orale Einnahme, Implantaten, Intrauterinvorrichtungen, Diaphragmen oder Supposi-A polymer produced and cured in this way sets the active ingredient under the influence of aqueous solutions, Salt solutions or body fluids are slowly released. The resin composition described in this example can can therefore be brought into any suitable form, for example tablets for oral ingestion, implants, Intrauterine devices, diaphragms, or suppositories
3 3 3 4 4 L υ3 3 3 4 4 L υ
torien verarbeitet werden, woraus sich der Wirkstoff gesteuert freisetzen läßt. Gewünschtenfalls kann man das Diaphragma oder die empfängnisverhütende Vorrichtung während der Herstellung mit einem empfängnisverhütenden Mittel versetzen, wie Milchsäure.torien are processed, from which the active ingredient is controlled can be released. If desired, the diaphragm or contraceptive device can be used during the manufacture with a contraceptive relocate, like lactic acid.
Man versetzt 305,5 Teile der in Beispiel 1 beschriebenen 9,82 %-igen Ethanollösung, die 30 Teile eines hydrophilen Polyurethanharzes enthält, mit 6,0 Teilen Methylacrylat und 0,427 Teilen t-Butylperoctanoat. Sodann wird das Lösungsmittel durch Verdampfung bei Raumtemperatur unter Vakuum entfernt, wodurch man zu einem Produkt aus 100 Teilen hydrophilem Polyurethan und 20 Teilen Methylacrylat gelangt. 305.5 parts of the 9.82% strength ethanol solution described in Example 1 and the 30 parts of a hydrophilic solution are added Contains polyurethane resin, with 6.0 parts of methyl acrylate and 0.427 parts of t-butyl peroctanoate. Then the solvent removed by evaporation at room temperature under vacuum, resulting in a product of 100 parts hydrophilic polyurethane and 20 parts of methyl acrylate.
Dieses Produkt kann in verschiedenartigen Formen gehärtet werden, indem man es in einem Ofen bei 121°C unter Stickstoff 30 bis 60 Minuten erhitzt. Die so erhaltene Polyurethan-Methylacrylat-Zusammensetzung nimmt 716 bis 758 % Wasser auf und hat einen Dehnwert von etwa 112 %.This product can be cured in various forms by heating it in an oven at 121 ° C under nitrogen for 30 to 60 minutes. The polyurethane-methyl acrylate composition thus obtained absorbs 716 to 758% water and has an elongation value of about 112%.
Wahlweise kann man die Polyurethan-Methylacrylat-Zusammensetzung auch zur Form einer flachen Bahn oder einer Kontaktlinse verpressen, indem man sie unter Druck in einer Presse bei 1000C erhitzt und die Temperatur unter Beibehaltung des Drucks dann 2 Minuten auf 1300C erhöht. Die erhaltene Bahn läßt sich als Membran zur Übertragung von QQ Wasser und Dampf verwenden, und sie eignet sich auch als chirurgisches Heftpflaster, das an einer Seite mit einem Klebstoff versehen sein kann, das sich besonders gut als Wundverband verwenden läßt, in den Medikamente, wie SuIfadiazin, eingearbeitet sein können. Die Polyurethan-Methyl-Q5 acrylat-Zusammensetzung, die nur 10 Gew.-% Methylacrylat enthält, ist auch als Dialysemembran geeignet und kann daher für Auftrenntechniken verwendet werden. Alternatively, the polyurethane-methyl acrylate composition can also be compressed to form a flat sheet or a contact lens by heating it under pressure in a press at 100 ° C. and then increasing the temperature to 130 ° C. for 2 minutes while maintaining the pressure. The web obtained can be used as a membrane for the transfer of QQ water and steam, and it is also suitable as a surgical adhesive plaster, which can be provided on one side with an adhesive which can be used particularly well as a wound dressing, in the medicaments, such as SuIfadiazin, may be incorporated. The polyurethane-methyl-Q5 acrylate composition, which contains only 10% by weight of methyl acrylate, is also suitable as a dialysis membrane and can therefore be used for separation techniques.
Beispiel 4Example 4
Unter Anwendung des in Beispiel 1 beschriebenen Verfahrens wird ausgehend von folgendem Gemisch eine Polyurethan-Methylmethacrylat-Zusammensetzung hergestellt:Using the method described in Example 1, starting from the following mixture, a polyurethane-methyl methacrylate composition is made manufactured:
Hydrophiles Polyurethan (9,8 %-igeHydrophilic polyurethane (9.8%
ethanolische Lösung von Beispiel 1) 305r5 Teileethanolic solution from Example 1) 305 r 5 parts
Methylmethacrylat 6,0 TeileMethyl methacrylate 6.0 parts
t-Butylperoctanoat 0,432 Teilet-butyl peroctanoate 0.432 parts
Diese Lösung kann bei Raumtemperatur unter Vakuum zur Trockne eingedampft werden, wodurch sich ein Produkt ergibt, das sich durch Extrusion unter Hitze und Druck in eine hydrophile Kanüle mit gewünschten physikalischen Eigenschaften überführen läßt. Vor der Extrusion kann das Harz gewünschtenfalls noch mit einem Medikament vermischt werden. Die Polyurethan-Acrylat-Zusammensetzung dieses Beispiels läßt sich in ethanolischer Lösung auch zur Beschichtung einer vorgeformten Kanüle verwenden, die man dann nach erfolgter Verdampfung des Lösungsmittels bei einer Temperatur von 1200C härten kann.This solution can be evaporated to dryness at room temperature under vacuum, resulting in a product which can be converted into a hydrophilic cannula with desired physical properties by extrusion under heat and pressure. If desired, the resin can also be mixed with a medicament prior to extrusion. The polyurethane-acrylate composition of this example can also be used in ethanolic solution to coat a preformed cannula, which can then be cured at a temperature of 120 ° C. after the solvent has evaporated.
Eine Härtung der obigen Zusammensetzung in einem Ofen bei 2010C unter inerter Atmosphäre während 30 Minuten ergibt ein Produkt mit einer Wasseraufnahme von 726 % und einem Dehnwert von 111 %.Curing the above composition in an oven at 201 0 C under an inert atmosphere for 30 minutes gives a product having a water absorption of 726% and a stretching rate of 111%.
Gehärtete gegossene oder geformte Filme, die sich als Wundverband eignen und die langsam Iod freisetzen, können aus der Harzzusammensetzung dieses Beispiels hergestellt werden, indem man in die Polyurethan-MethylmethacrylatwZusammensetzung nach ihrer Härtung Iod einarbeitet.Hardened cast or formed films which are suitable as a wound dressing and slowly release the iodine may be prepared from the resin composition of this example by w methyl methacrylate into the polyurethane composition by incorporating its cure iodine.
35Beispiel5 35 Example5
Die im Beispiel 1 beschriebene Lösung aus 305,5 Teilen hy-The solution described in Example 1 of 305.5 parts of hy-
drophilem Polyurethan (9,82 % Feststoffgehalt), 6 Teilen Hydroxyethylmethacrylat und 0,427 Teilen t-Butylperoctanoat in Ethanol wird in 3 Gew.-% Quecksilber(I)-acetat und 1 Gew.-% Bienenwachs, bezogen auf die Harzfeststoffe, suspendiert. Diese Lösung läßt sich dann auf das Äußere eines Boots aufbringen und durch die aktinische Strahlung der Sonne härten, wodurch ein unlöslicher Überzug entsteht, der den Strömungswiderstand erniedrigt und das Meereswachstum durch langsame Freisetzung von Quecksilber hemmt. 10drophilem polyurethane (9.82% solids), 6 parts Hydroxyethyl methacrylate and 0.427 parts of t-butyl peroctanoate in ethanol is in 3 wt .-% mercury (I) acetate and 1% by weight beeswax based on the resin solids, suspended. This solution can then be applied to the exterior of a boat and through the actinic radiation of the Sun harden, creating an insoluble coating that lowers drag and sea growth by slow release of mercury. 10
Die in Beispiel 1 beschriebene Lösung aus 305,5 Teilen hydrophilem Polyurethan (9,82 % Feststoffgehalt), 6 Teilen Hydroxyethylmethacrylat und 0,427 Teilen t-Butylperoctanoat in Ethanol wird zur Entfernung des Ethanols bei Raumtemperatur unter Vakuum gehalten. Der entstandene weiße Feststoff wird unterhalb der Härtungstemperatur unter Druck zu einem Schlauch extrudiert, den man anschließend härtet. Auf diese Weise gelangt man zu einem wasserdurchlässigen und gasdurchlässigen Schlauch. Ein solcher Schlauch eignet sich beispielsweise in Dialysegeräten für die Niere.The solution described in Example 1 of 305.5 parts of hydrophilic Polyurethane (9.82% solids), 6 parts Hydroxyethyl methacrylate and 0.427 parts of t-butyl peroctanoate in ethanol are used to remove the ethanol at room temperature kept under vacuum. The resulting white solid is below the curing temperature below Pressure is extruded into a tube, which is then cured. In this way one arrives at a water-permeable and gas-permeable hose. Such a tube is suitable, for example, in dialysis machines the kidney.
Claims (10)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08332382A GB2150938B (en) | 1983-12-05 | 1983-12-05 | Hydrophilic polyurethane acrylate compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3344001A1 true DE3344001A1 (en) | 1985-06-13 |
Family
ID=10552827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19833344001 Withdrawn DE3344001A1 (en) | 1983-12-05 | 1983-12-06 | HYDROPHILE POLYURETHANE ACRYLATE COMPOSITION AND THEIR USE |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE3344001A1 (en) |
| GB (1) | GB2150938B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2557576A1 (en) * | 1984-01-03 | 1985-07-05 | Gould Francis | Hydrophilic polyurethane acrylate composition, process for its preparation and its use as burn dressing, implant, contraceptive, intrauterine device, cannula, oral application system, gas-permeable membrane, corneal prosthesis, surgical dressing, dialysis membrane, contact lens and coating for boat hulls |
| DE4111098A1 (en) * | 1991-04-05 | 1992-10-08 | Beiersdorf Ag | HYDROPHILIC SHEARS AND METHOD FOR THE PRODUCTION THEREOF |
| DE102008023798A1 (en) * | 2008-05-15 | 2009-11-19 | Hans Hermann Schulz | Hydrogel, which is formed by in situ radiation curing of at least one urethane acrylate-precursor, useful for treating wounds, where the precursor is obtained from polyalkylene oxide, diisocyanate and unsaturated alcohol |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8611470D0 (en) * | 1986-05-10 | 1986-06-18 | Victaulic Plc | Moulding of plastics products |
| GB8629231D0 (en) * | 1986-12-06 | 1987-01-14 | Smith & Nephew Ass | Adhesive & dressings |
| DE3785311T2 (en) * | 1986-12-06 | 1993-07-22 | Smith & Nephew | ADHESIVE, METHOD FOR PRODUCING IT AND ITS USE. |
| US4874373A (en) * | 1987-03-03 | 1989-10-17 | Luther Ronald B | Dip formed catheter and assembly |
| WO1989003860A1 (en) * | 1987-10-14 | 1989-05-05 | Tyndale Plains-Hunter, Ltd. | Moisture sensitive elastomer compositions |
| GB8801863D0 (en) * | 1988-01-28 | 1988-02-24 | Fulmer Yarsley Ltd | Pharmaceutical formulations with controlled drug release |
| GB8918589D0 (en) * | 1989-08-15 | 1989-09-27 | Graham Neil B | Polymeric compositions |
| US5670111A (en) | 1990-01-10 | 1997-09-23 | Rochester Medical Corporation | Method of shaping structures with an overcoat layer including female urinary catheter |
| US5261896A (en) | 1990-01-10 | 1993-11-16 | Rochester Medical Corporation | Sustained release bactericidal cannula |
| US6626888B1 (en) | 1990-01-10 | 2003-09-30 | Rochester Medical Corporation | Method of shaping structures with an overcoat layer including female urinary catheter |
| US5269770A (en) | 1990-01-10 | 1993-12-14 | Rochester Medical Corporation | Microcidal agent releasing catheter with balloon |
| US5360402A (en) * | 1990-01-10 | 1994-11-01 | Rochester Medical Corporation | Hand-actuated retention catheter |
| US5971954A (en) | 1990-01-10 | 1999-10-26 | Rochester Medical Corporation | Method of making catheter |
| GB9101502D0 (en) * | 1991-01-23 | 1991-03-06 | Controlled Therapeutics Sct | Controlled release compositions |
| GB9217625D0 (en) * | 1992-08-19 | 1992-09-30 | Smith & Nephew Res | Polymer materials |
| RU2074673C1 (en) * | 1995-06-01 | 1997-03-10 | Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Elastic artificial crystalline lens and method for manufacturing same |
| AUPO185796A0 (en) * | 1996-08-26 | 1996-09-19 | Lions Eye Institute | Ocular socket prosthesis |
| US8864730B2 (en) | 2005-04-12 | 2014-10-21 | Rochester Medical Corporation | Silicone rubber male external catheter with absorbent and adhesive |
| GB0509690D0 (en) * | 2005-05-12 | 2005-06-15 | Medtrade Products Ltd | Film forming composition |
| DE102007002783A1 (en) | 2007-01-18 | 2008-08-07 | Bayer Materialscience Ag | Hydrogels of hydrophilic polyurethane (meth) acrylates |
| US9707375B2 (en) | 2011-03-14 | 2017-07-18 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
| US10092728B2 (en) | 2012-11-20 | 2018-10-09 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Sheath for securing urinary catheter |
| US9872969B2 (en) | 2012-11-20 | 2018-01-23 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Catheter in bag without additional packaging |
| CA2957085C (en) | 2014-08-26 | 2023-01-17 | C.R. Bard, Inc. | Packaging and hydrophilic coating of urinary catheter |
| CA3070865A1 (en) | 2017-09-19 | 2019-03-28 | C.R. Bard, Inc. | Urinary catheter bridging device, systems and methods thereof |
| CN114984297A (en) * | 2022-06-13 | 2022-09-02 | 湖北唯美医疗用品有限公司 | Preparation method of ultraviolet-cured rapid hemostatic hydrogel material and hemostatic hydrogel material prepared by same |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3145003A1 (en) * | 1980-11-12 | 1982-06-16 | Francis E. 08540 Princeton N.J. Gould | HYDROPHILE POLYURETHANDIACRYLATE COMPOSITION, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3653950A (en) * | 1970-04-22 | 1972-04-04 | Rohm & Haas | High impact resistant thermoplastic substrate coated with non-embrittling paint system |
| DE2259360C2 (en) * | 1972-12-04 | 1982-06-09 | Basf Ag, 6700 Ludwigshafen | Process for the production of thin layers based on polyurethane elastomers |
| GB1441108A (en) * | 1973-01-23 | 1976-06-30 | Redfarn C A | Cross linked polymers |
| CA1091384A (en) * | 1975-03-12 | 1980-12-09 | Louis J. Baccei | Curable poly(alkylene)ether polyol-based resins having improved properties |
| US4116786A (en) * | 1976-06-08 | 1978-09-26 | Union Carbide Corporation | Radiation curable coating compositions containing an acrylate-capped, polyether urethane and a polysiloxane |
| US4112017A (en) * | 1976-07-23 | 1978-09-05 | Lord Corporation | Radiation curable coating compositions |
| GB1590412A (en) * | 1976-08-02 | 1981-06-03 | Lord Corp | Radiation curable compositions |
| US4139436A (en) * | 1977-02-07 | 1979-02-13 | The Goodyear Tire & Rubber Company | Polyetherurethane composition and polymer prepared by photopolymerization |
| US4123421A (en) * | 1977-03-21 | 1978-10-31 | Witco Chemical Corporation | Stable tertiary amine containing terminally unsaturated polyurethane resins |
| CA1123547A (en) * | 1977-07-12 | 1982-05-11 | Charles H. Carder | Radiation curable composition |
| US4138299A (en) * | 1977-12-23 | 1979-02-06 | Armstrong Cork Company | Process utilizing a photopolymerizable and moisture curable coating containing partially capped isocyanate prepolymers and acrylate monomers |
| US4133723A (en) * | 1978-01-03 | 1979-01-09 | Lord Corporation | Actinic radiation-curable formulations from the reaction product of organic isocyanate, poly(alkylene oxide) polyol and an unsaturated addition-polymerizable monomeric compound having a single isocyanate-reactive hydrogen group |
| US4153778A (en) * | 1978-03-30 | 1979-05-08 | Union Carbide Corporation | Acrylyl capped urethane oligomers |
| US4337130A (en) * | 1980-06-25 | 1982-06-29 | E. I. Du Pont De Nemours And Company | Photocurable polyurethane film coatings |
| US4425468A (en) * | 1981-12-31 | 1984-01-10 | Ppg Industries, Inc. | Polyurea-polyurethane acrylate polymer dispersions |
-
1983
- 1983-12-05 GB GB08332382A patent/GB2150938B/en not_active Expired
- 1983-12-06 DE DE19833344001 patent/DE3344001A1/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3145003A1 (en) * | 1980-11-12 | 1982-06-16 | Francis E. 08540 Princeton N.J. Gould | HYDROPHILE POLYURETHANDIACRYLATE COMPOSITION, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2557576A1 (en) * | 1984-01-03 | 1985-07-05 | Gould Francis | Hydrophilic polyurethane acrylate composition, process for its preparation and its use as burn dressing, implant, contraceptive, intrauterine device, cannula, oral application system, gas-permeable membrane, corneal prosthesis, surgical dressing, dialysis membrane, contact lens and coating for boat hulls |
| DE4111098A1 (en) * | 1991-04-05 | 1992-10-08 | Beiersdorf Ag | HYDROPHILIC SHEARS AND METHOD FOR THE PRODUCTION THEREOF |
| DE102008023798A1 (en) * | 2008-05-15 | 2009-11-19 | Hans Hermann Schulz | Hydrogel, which is formed by in situ radiation curing of at least one urethane acrylate-precursor, useful for treating wounds, where the precursor is obtained from polyalkylene oxide, diisocyanate and unsaturated alcohol |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2150938B (en) | 1987-04-23 |
| GB8332382D0 (en) | 1984-01-11 |
| GB2150938A (en) | 1985-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3344001A1 (en) | HYDROPHILE POLYURETHANE ACRYLATE COMPOSITION AND THEIR USE | |
| DE3145003A1 (en) | HYDROPHILE POLYURETHANDIACRYLATE COMPOSITION, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF | |
| US4439585A (en) | Polyurethane diacrylate compositions as carrier for pharmacological agents | |
| US4439583A (en) | Polyurethane diacrylate compositions useful in forming canulae | |
| DE2831274C2 (en) | ||
| US4408023A (en) | Polyurethane diacrylate compositions useful for contact lenses and the like | |
| US4424305A (en) | Surgical implants formed of polyurethane diacrylate compositions | |
| DE69410459T2 (en) | STATISTICAL BLOCK COPOLYMERS | |
| DE69013926T2 (en) | POLYMER MATERIALS. | |
| US4780512A (en) | Polyurethane acrylate compositions | |
| DE68928264T2 (en) | Biostable, segmented, aliphatic polyurethanes and processes for their production | |
| US4798876A (en) | Hydrophilic polyurethane composition | |
| US4810582A (en) | Hydrophilic polyurethane composition | |
| US4451635A (en) | Polyurethane quaternary ammonium salts | |
| DE2527115A1 (en) | POLYURETHANE HYDROGELS | |
| DE1222669B (en) | Process for the production of polyurethanes with molding | |
| DE2310357B2 (en) | USE OF MULTIPLE FLUORALIPHATIC SIDE GROUPS CONTAINING OLIGOMERS AS ADHESIONS IN REINFORCED PLASTICS | |
| DE2423281A1 (en) | POLYTETRAMETHYLENE ETHERPOLYURETHANE / UREA RESINS | |
| JPH0343314B2 (en) | ||
| DE4243799A1 (en) | Siloxane block copolymer modified thermoplastic polyurethanes | |
| DE2827450A1 (en) | POLYURETHANE WITH LACTONE AND HYDROXYL GROUPS IN THE BASIC FRAMEWORK | |
| DE69530928T2 (en) | POLYURETHANE OBJECT IN A TUBULAR BALLOON SHAPE | |
| DE3005035A1 (en) | METHOD FOR PRODUCING POLYMERIZABLE POLYURETHANE ELASTOMERS | |
| US4439584A (en) | Gas and ion permeable membranes formed of polyurethane diacrylate compositions | |
| DE69600279T2 (en) | Foamed hot melt adhesive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8128 | New person/name/address of the agent |
Representative=s name: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 800 |
|
| 8130 | Withdrawal |